← Back to Brooks Laboratories Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

BROOKSPharmaceuticals

Brooks Laboratories Ltd — Financial Ratios & Key Metrics

₹37.11

-7.63%

P/E Ratio21.24xIndustry: 31.77x

ROE-12.21%Return on equity

ROCE-9.93%Return on capital

Debt/Equity0.07Low debt

💎

Valuation & Profitability

P/E Ratio

21.24x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹296.77 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

-17.61%

📉

Price Returns

1 Month

-8.02%

3 Months

-24.55%

6 Months

-29.13%

1 Year

-26.60%

52W Low

₹43

Current

₹37

52W High

₹164

-4% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹64

▼ Price below SMA 50 — Bearish

SMA 200

₹110

▼ Long-term downtrend

Volume Signal

222% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Brooks Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.